Cite
HARVARD Citation
Yoshii, Y. et al. (2016). 64Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133+ cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite. Cancer letters. 376 (1), pp. 74-82. [Online].